Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Allogeneic hematopoietic cell transplantation in dyskeratosis congenita: Short and long- term outcome of 183 consecutive patients transplanted at EBMT centers

Blood (2025) 146 (Supplement 1): 2490.

https://doi.org/10.1182/blood-2025-2490

Published: 2025

Journal Articles

Prognostic impact of mixed chimerism with undetectable measurable residual disease in pediatric and adolescent young adult patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies

Francesco Paolo Tambaro, Daniela Simonetti, Alessandra Cianflone, Veronica Tintori, Riccardo Masetti, Fulvio Porta, Gennaro Pagano, Marianna Maffeis, Mariachiara Sanvito, Arnalda Lanfranchi, Fabiana Cacace, Roberta Penta de Vera d'Aragona

Blood (2025) 146 (Supplement 1): 7782.

https://doi.org/10.1182/blood-2025-7782

Published: 2025

Journal Articles

Venetoclax and azacytidine in childhood primary advanced myelodysplastic syndromes, refractory/relapsed Acute Myeloid Leukemia and therapy-related myeloid diseases

Francesco Baccelli, Pietro Merli, Gennaro Pagano, Marco Becilli, Katia Girardi, Valeria Paganelli, Davide Leardini, Edoardo Muratore, Francesca Vendemini, Giuliana Beneduce, Manuela Tumino, Francesco Saglio, Elena Sieni, Elena Mastrodicasa, Francesco Paolo Tambaro, Riccardo Masetti, Franco Locatelli

Blood (2025) 146 (Supplement 1): 289.

https://doi.org/10.1182/blood-2025-289

Published: 2025

Journal Articles

Overestimation of collection volume with spectra optia: Determining factors and corrective strategies

Stefania Nappo, Mario Toriello, Maria Vittoria Mascio, Aurora Lione, Giovanna Maisto, Claudio Falco, Teresa Nutile, Francesco Paolo Tambaro, Roberta Penta de Vera d'Aragona

Blood (2025) 146 (Supplement 1): 7704.

https://doi.org/10.1182/blood-2025-7704

Published: 2025

Journal Articles

Acute Lymphoblastic Leukemia in Shwachman-Diamond Syndrome: Challenges and Treatment Outcomes

Fabiana Cacace, Emanuela Rossitti, Gennaro Pagano, Valeria Caprioli, Maria Rosaria D'Amico, Giuseppina De Simone, Giovanna Giagnuolo, Rosanna Parasole, Maria Simona Sabbatino, Pio Stellato, William G. Wierda, Francesco Paolo Tambaro

Blood (2024) 144 (Supplement 1): 5710.

https://doi.org/10.1182/blood-2024-201273

Published: 2024

Journal Articles

Gelofusine As Alternative to Dextran40 for Washing Cryopreserved Hematopoietic Stem Cell Products Prior to Infusion: Validation and Application to Clinical Practice

Stefania Nappo, Mario Toriello, Giovanna Maisto, Francesco Topo, Lucia Gallo, Giovanni Castellano, Roberta Penta de Vera d'aragona, Emanuela Rossitti, Alessandra Picardi, William G. Wierda, Francesco Paolo Tambaro

Blood (2024) 144 (Supplement 1): 2095.

https://doi.org/10.1182/blood-2024-209742

Published: 2024

Journal Articles

Role of Adenovirus Reactivation on Blood and Stool Samples in Pediatric Hematopoietic Stem Cell Transplantation

Francesco Delle Cave, Virginia Brizzi, Mariangela Siciliano, Jessica Rotella, Francesco Paolo Tambaro, Arianna Panigari, Francesca Compagno, Patrizia Comoli, Marco Zecca

Blood (2024) 144 (Supplement 1): 7291.

https://doi.org/10.1182/blood-2024-207651

Published: 2024

Journal Articles

Donor-Derived NK Cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplant for High-Risk and Relapsed/Refractory Pediatric Leukemia

Emanuela Rossitti, Gennaro Pagano, Fabiana Cacace, Valeria Caprioli, Maria Rosaria D'Amico, Giuseppina De Simone, Maria Simona Sabbatino, Mario Toriello, Giovanna Maisto, Roberta Penta de Vera d'aragona, Alessandra Cianflone, Peppino Mirabelli, William G. Wierda, Francesco Paolo Tambaro

Blood (2024) 144 (Supplement 1): 7189.

https://doi.org/10.1182/blood-2024-200707

Published: 2024

Journal Articles

Early Obinutuzumab Significantly Increases Bone Marrow Undetectable MRD (10 -4 sensitivity) (uMRD4) Rate When Combined with Acalabrutinib and Venetoclax in a Randomized Phase II Trial for Treatment Naïve CLL

Blood (2024) 144 (Supplement 1): 1855.

https://doi.org/10.1182/blood-2024-211110

Published: 2024

Journal Articles

Qol-Blina Protocol: Preliminary Data of a Paediatric Italian Multicentric Study

Fara Petruzziello, Roberto Capasso, Gaia Sepe, Giuseppe Menna, Francesco Paolo Tambaro, Rosanna Parasole

Blood (2024) 144 (Supplement 1): 1423.

https://doi.org/10.1182/blood-2024-203062

Published: 2024

Journal Articles

How I manage CLL with venetoclax-based treatments

William G. Wierda, Francesco Paolo Tambaro

Blood (2020) 135 (17): 1421–1427.

https://doi.org/10.1182/blood.2019002841

Published: 2020

Journal Articles

CpG-Stimulated Cytogenetic Abnormalities Associated with Shorter Time-to-First Treatment

Francesco Paolo Tambaro, MD PhD, Clelia Criscuolo, MD, Nitin Jain, MD, Alessandra Ferrajoli, MD, Philip A Thompson, MBBS, Jan Burger, MD PhD, Zeev Estrov, MD, Mimmo Ripaldi, MD, Hagop M. Kantarjian, MD, Susan M. O'Brien, MD, Michael Keating, MBBS, William G. Wierda, MD PhD

Blood (2016) 128 (22): 4351.

https://doi.org/10.1182/blood.V128.22.4351.4351

Published: 2016

Journal Articles

Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL

Paolo Strati, Michael J. Keating, Susan M. O'Brien, Jan Burger, Alessandra Ferrajoli, Nitin Jain, Francesco Paolo Tambaro, Zeev Estrov, Jeffrey Jorgensen, Pramoda Challagundla, Stefan H. Faderl, William G. Wierda

Blood (2014) 123 (24): 3727–3732.

https://doi.org/10.1182/blood-2013-11-538116

Published: 2014

Includes: Supplemental data

Journal Articles

Fludarabine, Bendamustine, and Rituximab (FBR) Chemoimmunotherapy Is a Safe and Active Regimen for Relapsed/Refractory CLL with in Vivo Mechanism of Action for Combination Chemotherapy

William G. Wierda, MD, PhD, Kumudha Balakrishnan, Alessandra Ferrajoli, M.D., Susan O'Brien, M.D., Jan A. Burger, MD, PhD, Tapan M. Kadia, M.D., Jorge E. Cortes, MD, Francesco Paolo Tambaro, MD, PhD, Annette Jalayer, RN, Susan Lerner, MS, Michael J. Keating, MD, Varsha V. Gandhi, Ph.D.

Blood (2012) 120 (21): 437.

https://doi.org/10.1182/blood.V120.21.437.437

Published: 2012

Journal Articles

A Prognostic Score System for Survival in Secondary AML: Review of 1073 Patients Observed At MDACC

Francesco Paolo Tambaro, MD, PhD, Guillermo Garcia-Manero, MD, Wei Qiao, Sherry A. Pierce, RN, BS, Mimmo Ripaldi, MD, Stefan Faderl, MD, Hagop M Kantarjian, William G. Wierda, MD, PhD, Jorge E Cortes, MD

Blood (2012) 120 (21): 131.

https://doi.org/10.1182/blood.V120.21.131.131

Published: 2012

Journal Articles

ROS Activation Independent From Iron Overload in MDS

Francesco Paolo Tambaro, MD, PhD, William G. Wierda, MD, PhD, Sherry Pierce, RN, BS, Hui Yang, MD, PhD, Yue Wei, PhD, Zhihong Fang, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero

Blood (2011) 118 (21): 2798.

https://doi.org/10.1182/blood.V118.21.2798.2798

Published: 2011

Journal Articles

Final Report of a Phase II Trial of Vorinostat with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Guillermo Garcia-Manero, Francesco Paolo Tambaro, MD, PhD, Nebiyou Bekele, Hui Yang, Farhad Ravandi, MD, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Marina Konopleva, M.D., Ph.D., Stefan Faderl, MD, Jorge E. Cortes, Mark Brandt, BS, Yumin Hu, PhD, Deborah McCue, Willie Mae Newsome, RN, Sherry Pierce, RN, BS, Marcos DeLima, MD, Hagop M. Kantarjian

Blood (2011) 118 (21): 763.

https://doi.org/10.1182/blood.V118.21.763.763

Published: 2011

Journal Articles

Acute Leukemia and Myelodysplastic Syndrome: Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL) At MD Anderson Cancer Center (MDACC)

Francesco Paolo Tambaro, MD, PhD, Guillermo Garcia-Manero, Stefan Faderl, MD, Susan O'Brien, MD, Alessandra Ferrajoli, MD, Jan A. Burger, MD, PhD, Long Xuan Trinh, Susan Lerner, MS, BA, Hagop M. Kantarjian, Michael J Keating, MD, William G. Wierda, MD, PhD

Blood (2011) 118 (21): 981.

https://doi.org/10.1182/blood.V118.21.981.981

Published: 2011

Journal Articles

A Phase I/II Trial of Fludarabine, Bendamustine, and Rituximab (FBR) Chemoimmunotherapy for Previously Treated Patients with CLL,

William G. Wierda, MD, PhD, Kumudha Balakrishnan, Alessandra Ferrajoli, MD, Tapan Kadia, Jorge E. Cortes, Susan O'Brien, MD, Jan A. Burger, MD, PhD, Francesco Paolo Tambaro, MD, PhD, Annette Jalayer, RN, Susan Lerner, MS, BA, Michael J Keating, MD, Varsha Gandhi, PhD

Blood (2011) 118 (21): 3901.

https://doi.org/10.1182/blood.V118.21.3901.3901

Published: 2011

Journal Articles

BARD1: a New Target In Leukemia

Francesco Paolo Tambaro, MD, PhD, Ilaria Lepore, Carmela Dell Aversana, Floriana De Bellis, Marco Miceli, Vincenzo Carafa, Angela Nebbioso, Felicetto Ferrara, MD, Guillermo garcia Manero, MD, Lucia Altucci

Blood (2010) 116 (21): 4642.

https://doi.org/10.1182/blood.V116.21.4642.4642

Published: 2010

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Allogeneic hematopoietic cell transplantation in dyskeratosis congenita: Short and long- term outcome of 183 consecutive patients transplanted at EBMT centers

Prognostic impact of mixed chimerism with undetectable measurable residual disease in pediatric and adolescent young adult patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies

Venetoclax and azacytidine in childhood primary advanced myelodysplastic syndromes, refractory/relapsed Acute Myeloid Leukemia and therapy-related myeloid diseases

Overestimation of collection volume with spectra optia: Determining factors and corrective strategies

Acute Lymphoblastic Leukemia in Shwachman-Diamond Syndrome: Challenges and Treatment Outcomes

Gelofusine As Alternative to Dextran40 for Washing Cryopreserved Hematopoietic Stem Cell Products Prior to Infusion: Validation and Application to Clinical Practice

Role of Adenovirus Reactivation on Blood and Stool Samples in Pediatric Hematopoietic Stem Cell Transplantation

Donor-Derived NK Cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplant for High-Risk and Relapsed/Refractory Pediatric Leukemia

Early Obinutuzumab Significantly Increases Bone Marrow Undetectable MRD (10 -4 sensitivity) (uMRD4) Rate When Combined with Acalabrutinib and Venetoclax in a Randomized Phase II Trial for Treatment Naïve CLL

Qol-Blina Protocol: Preliminary Data of a Paediatric Italian Multicentric Study

How I manage CLL with venetoclax-based treatments

CpG-Stimulated Cytogenetic Abnormalities Associated with Shorter Time-to-First Treatment

Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL

Fludarabine, Bendamustine, and Rituximab (FBR) Chemoimmunotherapy Is a Safe and Active Regimen for Relapsed/Refractory CLL with in Vivo Mechanism of Action for Combination Chemotherapy

A Prognostic Score System for Survival in Secondary AML: Review of 1073 Patients Observed At MDACC

ROS Activation Independent From Iron Overload in MDS

Final Report of a Phase II Trial of Vorinostat with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Acute Leukemia and Myelodysplastic Syndrome: Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL) At MD Anderson Cancer Center (MDACC)

A Phase I/II Trial of Fludarabine, Bendamustine, and Rituximab (FBR) Chemoimmunotherapy for Previously Treated Patients with CLL,

BARD1: a New Target In Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only